Payments from drug companies to physicians are associated with higher volume and more expensive opioid analgesic prescribing.
BACKGROUND:While the rise in opioid analgesic prescribing and overdose deaths was multifactorial, financial relationships between opioid drug manufacturers and physicians may be one important factor. METHODS:Using national data from 2013 to 2015, we conducted a retrospective cohort study linking the...
Main Authors: | Mark A Zezza, Marcus A Bachhuber |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC6300290?pdf=render |
Similar Items
-
Quality Improvement Initiative to Decrease Variability of Emergency Physician Opioid Analgesic Prescribing
by: John H. Burton, et al.
Published: (2016-05-01) -
Prescribing databases can be used to monitor trends in opioid analgesic prescribing in Australia
by: Samantha A. Hollingworth, et al.
Published: (2013-04-01) -
Differential Prescribing of Opioid Analgesics According to Physician Specialty for Medicaid Patients with Chronic Noncancer Pain Diagnoses
by: Chris Ringwalt, et al.
Published: (2014-01-01) -
Prescribing support software recommends more expensive prescriptions
by: Simon de Lusignan
Published: (2008-05-01) -
Variations in Opioid Prescribing Behavior by Physician Training
by: Evan L. Leventhal, et al.
Published: (2019-04-01)